Related Experiment Video
Updated: Aug 4, 2026

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction
Published on: February 13, 2021
Standardized Definitions for Evaluation of Heart Failure Therapies: Scientific Expert Panel From the Heart Failure
William T Abraham1, Mitchell A Psotka2, Mona Fiuzat3
1Division of Cardiovascular Medicine, The Ohio State University, Columbus, Ohio, USA.
Insights
The Heart Failure Academic Research Consortium provides consensus recommendations for heart failure (HF) clinical trial design. These guidelines aim to standardize definitions and improve innovation in evaluating HF therapies.
Area of Science:
- Cardiology
- Clinical Trials
- Regulatory Science
Background:
- Heart failure (HF) requires standardized evaluation methods for therapies.
- Existing clinical trial designs may benefit from updated consensus definitions.
- Collaboration between academic investigators, regulatory bodies, and industry is crucial.
Purpose of the Study:
- To establish consensus definitions and key concepts for evaluating HF therapies.
- To provide recommendations on optimal medical and device background therapy.
- To guide clinical trial design elements, statistical concepts, and study endpoints for HF research.
Main Methods:
- Convening a series of expert panel meetings.
- Facilitating discussions among leading HF academic investigators, patients, and representatives from regulatory agencies and industry.
- Synthesizing expert discussions into consensus recommendations.
Main Results:
- Developed consensus recommendations for HF populations and endpoint definitions.
- Addressed optimal medical and device background therapy considerations.
- Provided insights into clinical trial design and statistical concepts.
Conclusions:
- The recommendations aim to stimulate innovation in HF clinical trial design.
- Standardized definitions and concepts are essential for robust HF therapy evaluation.
- This work serves as a foundation for future HF research and drug development.
Abstract:
The Heart Failure Academic Research Consortium is a partnership between the Heart Failure Collaboratory (HFC) and Academic Research Consortium (ARC), comprised of leading heart failure (HF) academic research investigators, patients, United States (US) Food and Drug Administration representatives, and industry members from the US and Europe. A series of meetings were convened to establish definitions and key concepts for the evaluation of HF therapies including optimal medical and device background therapy, clinical trial design elements and statistical concepts, and study endpoints. This manuscript summarizes the expert panel discussions as consensus recommendations focused on populations and endpoint definitions; it is not exhaustive or restrictive, but designed to stimulate HF clinical trial innovation.
More Related Videos
Related Concept Videos
Pathophysiology of Heart Failure
Heart Failure III: Clinical Manifestations
Heart Failure IV: Classification and Diagnostic Evaluation
Heart Failure V: Medical Management
Heart Failure VI: Adjunct Therapies
Heart Failure VII: Nursing Interventions

